Beck Joins Biopharma Problem-Solving Klyo Collaborative

  • May 19, 2015

Beck joined fellow members of the Klyo Collaborative to launch the alliance’s mission to the press at Interphex 2015 on April 21, 2015. This new collaborative problem-solving group is aimed at assisting biopharmaceutical companies in solving their most pressing lifecycle pipeline problems.

Why Klyo? The term is Greek for “to hear, to listen” and reflects the alliance’s focus on listening to and solving biopharmaceutical challenges.

This new alliance has already demonstrated a number of successes solving lifecycle problems for the biopharmaceutical industry. The team will focus on offering innovative solutions for early stage biotech firms looking to accelerate development timelines, as well as all-inclusive approaches for larger pharmaceutical companies experiencing a decline in internal resources with mounting pressure to deliver an increasingly diverse global supply of safe pharmaceutical products.